-+ 0.00%
-+ 0.00%
-+ 0.00%

Reliance Global invests USD 2 million in Innervate Radiopharmaceuticals via LifeSci Global

PUBT·05/04/2026 12:17:17
Listen to the news
Reliance Global invests USD 2 million in Innervate Radiopharmaceuticals via LifeSci Global
  • Reliance Global Group, through majority-owned LifeSci Global, completed a minority equity investment in Innervate Radiopharmaceuticals.
  • LifeSci Global will acquire 421,053 Innervate shares at USD 4.75 each, implying a total commitment of about USD 2 million.
  • USD 500,000 was funded at closing, with a unilateral right to accelerate remaining funding.
  • Transaction gives entry into late-stage PET imaging and therapeutic radiopharmaceutical platform led by 18F-mFBG for neuroblastoma, with potential expansion into cardiovascular and neurodegenerative indications.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reliance Global Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040817PRIMZONEFULLFEED9711781) on May 04, 2026, and is solely responsible for the information contained therein.